Monopar Announces Filing Of Patent Protecting MNPR-101 Radiopharma Optimization Findings
Monopar Therapeutics Inc. (NASDAQ:MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that it has filed a provisional patent application